Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β-catenin signaling pathway

Journal of Neuroscience Research

Volumn 91, Issue 1, 2013, Pages 30-41

  Chen, Bei Yu ^a   Wang, Xi ^b   Wang, Zhao Yan ^c   Wang, Ya Zhou ^b   Chen, Liang Wei ^b   Luo, Zhuo Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

BDNF; Neural stem cells; Stem cell therapy; TOPgal mice; Wnt catenin signaling

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE PROTEIN; PROTRIN TUJ 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; GLIA; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NEURAL STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84869166433     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23138     Document Type: Article

References (62)

1. Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, Offen D. 2009. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J Mol Neurosci 39: 199-210.
2. Bamji SX, Rico B, Kimes N, Reichardt LF. 2006. BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-beta-catenin interactions. J Cell Biol 174: 289-299.
3. Baquet ZC, Bickford PC, Jones KR. 2005. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25: 6251-6259.
4. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM. 2009. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106: 13594-13599.
5. Brown JB, Cheresh P, Goretsky T, Managlia E, Grimm GR, Ryu H, Zadeh M, Dirisina R, Barrett TA. 2011. Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection. Infect Immun 79: 1863-1872.
6. Canudas AM, Pezzi S, Canals JM, Pallàs M, Alberch J. 2005. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury. Brain Res Mol Brain Res 134: 147-154.
7. Casalbore P, Barone I, Felsani A, D'Agnano I, Michetti F, Maira G, Cenciarelli C. 2010. Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways. J Cell Physiol 224: 710-721.
8. Castelo-Branco G, Arenas E. 2006. Function of Wnts in dopaminergic neuron development. Neurodegen Dis 3: 5-11.
9. Castelo-Branco G, Wagner J, Rodriguez FJ, Kele J, Sousa K, Rawal N, Pasolli HA, Fuchs E, Kitajewski J, Arenas E. 2003. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A 100: 12747-12752.
10. Castelo-Branco G, Andersson ER, Minina E, Sousa KM, Ribeiro D, Kokubu C, Imai K, Prakash N, Wurst W, Arenas E. 2010. Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev Dyn 239: 211-221.
11. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L. 2009. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107.
12. Chen LW, Yung KL, Chan YS. 2005. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr Drug Targets 6: 821-833.
13. Chung S, Leung A, Han BS, Chang MY, Moon JI, Kim CH, Hong S, Pruszak J, Isacson O, Kim KS. 2009. Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 5: 646-658.
14. David MD, Yeramian A, Duñach M, Llovera M, Cantí C, de Herreros AG, Comella JX, Herreros J. 2008. Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation. J Cell Sci 121: 2718-2730.
15. De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC. 2003. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry 8: 195-208.
16. Gibrat C, Bousquet M, Saint-Pierre M, Lévesque D, Calon F, Rouillard C, Cicchetti F. 2010. Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor. Prog Neuropsychopharmacol Biol Psychiatry 34: 193-203.
17. Giralt A, Friedman HC, Caneda-Ferrón B, Urbán N, Moreno E, Rubio N, Blanco J, Peterson A, Canals JM, Alberch J. 2010. BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. Gene Ther 17: 1294-1308.
18. Gyárfás T, Knuuttila J, Lindholm P, Rantamäki T, Castrén E. 2010. Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol Neurobiol 30: 361-368.
19. Hagg T. 1998. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp Neurol 149: 183-192.
20. Hudson JE, Titmarsh DM, Hidalgo A, Wolvetang EJ, Cooper-White JJ. 2011. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev [E-pub ahead of print].
21. Hutchison MR. 2012. BDNF Alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes. Mol Endocrinol [Jun 14 E-pub ahead of print].
22. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232.
23. Isacson O, Kordower JH. 2008. Future of cell and gene therapies for Parkinson's disease. Ann Neurol 64(Suppl 2): S122-S138.
24. Islam O, Loo TX, Heese K. 2009. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res 6: 42-53.
25. Jin C, Samuelson L, Cui CB, Sun Y, Gerber DA. 2011. MAPK/ERK and Wnt/β-catenin pathways are synergistically involved in proliferation of Sca-1 positive hepatic progenitor cells. Biochem Biophys Res Commun 409: 803-807.
26. Katsuki H, Kurimoto E, Takemori S, Kurauchi Y, Hisatsune A, Isohama Y, Izumi Y, Kume T, Shudo K, Akaike A. 2009. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J Neurochem 110: 707-718.
27. Krejci P, Aklian A, Kaucka M, Sevcikova E, Prochazkova J, Masek JK, Mikolka P, Pospisilova T, Spoustova T, Weis M, Paznekas WA, Wolf JH, Gutkind JS, Wilcox WR, Kozubik A, Jabs EW, Bryja V, Salazar L, Vesela I, Balek L. 2012. Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS One 7: e35826.
28. Lee HJ, Lim IJ, Lee MC, Kim SU. 2010. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 88: 3282-3294.
29. Li B, Piao CS, Liu XY, Guo WP, Xue YQ, Duan WM, Gonzalez-Toledo ME, Zhao LR. 2010. Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia. Brain Res 1327: 91-102.
30. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, Dearie AR, Gage FH. 2005. Wnt signalling regulates adult hippocampal neurogenesis. Nature 437: 1370-1375.
31. Lim JY, Park SI, Oh JH, Kim SM, Jeong CH, Jun JA, Lee KS, Oh W, Lee JK, Jeun SS. 2008. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res 86: 2168-2178.
32. Mullen LM, Pak KK, Chavez E, Kondo K, Brand Y, Ryan AF. 2012. Ras/p38 and PI3K/Akt but not Mek/Erk signaling mediate BDNF-induced neurite formation on neonatal cochlear spiral ganglion explants. Brain Res 1430: 25-34.
33. Nguyen N, Lee SB, Lee YS, Lee KH, Ahn JY. 2009. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 34: 942-951.
34. Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. 2010. BDNF function and intracellular signaling in neurons. Histol Histopathol 25: 237-258.
35. Perry JM, He XC, Sugimura R, Grindley JC, Haug JS, Ding S, Li L. 2011. Cooperation between both Wnt/beta-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev 25: 1928-1942.
36. 2A antagonist ketanserin upregulates hippocampal BDNF and β-catenin in parallel with antidepressant-like effect. Br J Pharmacol [May 31 E-pub ahead of print].
37. Pinnock SB, Blake AM, Platt NJ, Herbert J. 2010. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS One 5: e13652.
38. Porritt MJ, Batchelor PE, Howells DW. 2005. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons. Exp Neurol 192: 226-234.
39. Prakash N, Wurst WA. 2007. Wnt signal regulates stem cell fate and differentiation in vivo. Neurodegen Dis 4: 333-338.
40. Prakash N, Brodski C, Naserke T, Puelles E, Gogoi R, Hall A, Panhuysen M, Echevarria D, Sussel L, Weisenhorn DM, Martinez S, Arenas E, Simeone A, Wurst WA. 2006. Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133: 89-98.
41. Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Ilan AB, Bulvik S, Shemesh N, Krepel D, Cohen Y, Melamed E, Offen D. 2009. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev 18: 1179-1190.
42. Santos AR, Comprido D, Duarte CB. 2010. Regulation of local translation at the synapse by BDNF. Prog Neurobiol 92: 505-916.
43. Seitz R, Hackl S, Seibuchner T, Tamm ER, Ohlmann A. 2010. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J Neurosci 30: 5998-6010.
44. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. 2010. Intranigral transplantation of epigenetically-induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. Biol Blood Marrow Transplant 16: 1530-1540.
45. Sun CY, Hu Y, Huang J, Chu ZB, Zhang L, She XM, Chen L. 2010. Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling. Tumour Biol 31: 121-128.
46. Tang M, Miyamoto Y, Huang EJ. 2009. Multiple roles of beta-catenin in controlling the neurogenic niche for midbrain dopamine neurons. Development 136: 2027-2038.
47. Tenbaum SP, Ordóñez-Morán P, Puig I, Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Cajal SR, Schwartz SJr, Vivancos A, Espín E, Rojas S, Baselga J, Tabernero J, Muñoz A, Palmer HG. 2012. β-Catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med [May 20 E-pub ahead of print].
48. Tsutsumi T, Terao T, Hatanaka K, Goto S, Hoaki N, Wang Y. 2011. Association between affective temperaments and brain-derived neurotrophic factor, glycogen synthase kinase 3β and Wnt signaling pathway gene polymorphisms in healthy subjects. J Affect Disord 131: 353-357.
49. Van't Veer A, Du Y, Fischer TZ, Boetig DR, Wood MR, Dreyfus CF. 2009. Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway. J Neurosci Res 87: 69-78.
50. Volpicelli F, Caiazzo M, Greco D, Consales C, Leone L, Perrone-Capano C, Colucci D'Amato L, di Porzio U. 2007. Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro. J Neurochem 102: 441-453.
51. Wada A, Yokoo H, Yanagita T, Kobayashi H. 2005. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99: 307-321.
52. Wang YZ, Molotkov A, Song L, Li Y, Pleasure DE, Zhou CJ. 2008. Activation of the Wnt/beta-catenin signaling reporter in developing mouse olfactory nerve layer marks a specialized subgroup of olfactory ensheathing cells. Dev Dyn 237: 3157-3168.
53. Wang ZH, Ji Y, Shan W, Zeng B, Raksadawan N, Pastores GM, Wisniewski T, Kolodny EH. 2002. Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease. Neuroscience 113: 629-640.
54. Wei R, Lin CM, Tu YY. 2010. Strain-specific BDNF expression of rat primary astrocytes. J Neuroimmunol 220: 90-98.
55. Weinreb O, Amit T, Bar-Am O, Youdim MB. 2007. Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. Ann N Y Acad Sci 1122: 155-168.
56. Widelitz R. 2005. Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23: 111-116.
57. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR3rd, Nusse R. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
58. Yacoubian TA, Standaert DG. 2009. Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta 1792: 676-687.
59. Yang D, Peng C, Li X, Fan X, Li L, Ming M, Chen S, Le W. 2008. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures. J Neurosci Res 86: 3393-3400.
60. Yoshii A, Constantine-Paton M. 2010. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70: 304-322.
61. Zawada WM, Kirschman DL, Cohen JJ, Heidenreich KA, Freed CR. 1996. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp Neurol 140: 60-67.
62. Zhou J, Bradford HF, Stern GM. 1997. Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. Brain Res Dev Brain Res 100: 43-51.